a
Zimmer lost $9.2 million after a Los Angeles jury ruled in favor of a man who claimed the Durom Cup caused him permanent injuries, according to drugwatch.
Here are 29 key notes on orthopedic and spine device companies over the past week.
ResearchMoz.us released its "BRIC Spinal Surgery Market Outlook to 2020" report, which includes numbers on industry size, shares, growth, analysis, trends and forecast.
Integra LifeSciences reported a second quarter revenue increase and full-year guidance after the SeaSpine spin-off completes.

5. EOS imaging names new board chairman: 5 key notes

Written by Laura Dyrda | Friday, 31 July 2015 00:00
EOS imaging, a Paris-based company focused on two-dimensional and three-dimensional orthopedic medical imaging equipment, appointed a new board member chairman.
Teleflex, a global provider of medical devices for critical care and surgery, signed a group purchasing agreement with HealthTrust.
Carl Lauryssen, MD, a spine surgeon with NeuroTexas, will be co-principal investigator of the study for the M6-C Artificial spinal disc at Lakeway Regional Medical Center.
Valence Health, a clinical integration, population health and value-based care solutions provider, named Andrew Eckert CEO. He will start his new position on Aug. 3.
Health Care Service Corp., the nation's largest customer-owned health insurer, will collaborate with MATTER, a Chicago health technology incubator.
Smith & Nephew, a global medical technology business, appointed Robin Freestone to its board as non-executive director and member of the audit committee.
Histogenics appointed Stephen Kennedy as chief technology officer, effective immediately.

12. ISTO Technologies receives NIH research grant: 5 facts

Written by Anuja Vaidya | Thursday, 30 July 2015 00:00
ISTO Technologies recently received a Small Business Innovation Research grant from the National Institutes of Health.
NuVasive shares jumped 10 percent yesterday. Here's why, according to Motley Fool.
SeaSpine released preliminary financial results for the company's first quarter as a separate entity from Integra LifeSciences.

15. Smith & Nephew Q2 revenue up 5%: 8 things to know

Written by Laura Dyrda | Thursday, 30 July 2015 00:00
Smith & Nephew reported an increase in second quarter revenue.
The Food and Drug Administration granted 44 spine- and orthopedic-driven device clearances in June.
Leerink Swann analysts reaffirmed Stryker stock's "outperform" rating, according to the Legacy.
Nevro announced that the results of the SENZA-RCT study were published online in Anesthesiology, the official journal of the American Society of Anesthesiologists.
Spine Pain Management has received a final patent allowing all claims for its Quad Video HALO.
BioStructures' Signafuse Bioactive Bone Graft Putty has been used in 4,000 implantations.
  • «
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  • »
Page 1 of 230

Top 40 Articles from the Past 6 Months